News by subject: Share Issue

Regulatory News: Lysogene (Paris:LYS) (FR0013233475 ? LYS), a phase 3 gene therapy platform Company targeting central nervous system (CNS) diseases, announces a change in the governance and control of KGA, a company co-owned by Karen Aiach and which...

Eros STX Global Corporation ("ErosSTX" or the "Company"), a global entertainment company, today submitted to the SEC a Registration Statement on Form F-3 that registers the offer and sale of, among other things, approximately 196.3 million ErosSTX A...

Ondas Holdings Inc. (the "Company") today announced that in connection with its previously announced public offering (the "Offering") of its common stock, par value $0.0001 per share (the "Common Stock"), the underwriters exercised in full and...

Alta Equipment Group Inc. ("Alta" or the "Company"), a leading provider of premium industrial and construction equipment and related services, today announced it has filed a registration statement on Form S-1/A with the U.S. Securities and Exchange...

Castle Biosciences, Inc. , announced today the pricing of its underwritten public offering of 4,000,000 shares of its common stock at a price to the public of $58.00 per share. The gross proceeds to Castle from the offering, before deducting...

ContextLogic Inc. (d/b/a "Wish") today announced the pricing of its initial public offering of 46,000,000 shares of its Class A common stock at a price to the public of $24.00 per share. The shares are expected to begin trading on the Nasdaq Global...

Regulatory News: NANOBIOTIX (Paris:NANO) (Euronext : NANO ? ISIN : FR0011341205 ? the ??Company''), a clinical-stage nanomedicine company pioneering new approaches to the treatment of cancer, today announced the initial closing of its previously...

Morgan Stanley today declared a regular dividend on the outstanding shares of each of the following preferred stock issues: Floating Rate Non-Cumulative Preferred Stock, Series A - $255.56 per share (equivalent to $0.25556 per Depositary Share)...

Prosus is pleased to announce that its ordinary shares N have been approved for inclusion in the list of qualifying equity securities to be listed and traded on A2X with effect from 23 December 2020 (the ?A2X listing date'). Prosus will retain its...

New Fortress Energy Inc. (the "Company") announced today that it intends to offer $250 million aggregate principal amount of additional 6.750% senior secured notes due 2025 (the "Additional Notes") in a private offering, subject to market...

Castle Biosciences, Inc. , announced today that it has commenced a proposed underwritten public offering, subject to market and other conditions, to issue and sell $125,000,000 of shares of its common stock. In connection with the offering, Castle...

PQ Group Holdings Inc. , a leading integrated and innovative global provider of specialty catalysts, chemicals and services, announced today that it has completed the sale of its Performance Materials business for a purchase price of $650 million,...

RMG Acquisition Corp. II (the "Company") announced today the closing of its initial public offering of 34,500,000 units, which included the full exercise of the underwriters' over-allotment option, at a price of $10.00 per unit, resulting in gross...

Sequans Communications S.A. , ("Sequans" or the "Company"), a leading developer and provider of 5G and 4G chips and modules for IoT devices, today announced that the underwriter of the previously announced public secondary offering of American...

Mirum Pharmaceuticals, Inc. , a biopharmaceutical company focused on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases, today announced that it has commenced an underwritten public...

United Natural Foods, Inc. (the "Company" or "UNFI") announced today that on December 11, 2020, it granted a restricted stock unit ("RSU") award to R. Eric Esper, its Chief Accounting Officer and Controller, covering a total of 43,324 shares of...

Tekkorp Digital Acquisition Corp. (the "Company") today announced that, commencing December 14, 2020, holders of the units sold in the Company's initial public offering of 25,000,000 units completed on October 26, 2020, may elect to separately trade...

FireEye, Inc. , the intelligence-led security company, today announced that the $400 million strategic investment led by funds managed by Blackstone Tactical Opportunities ("Blackstone") has closed. Blackstone was joined by ClearSky, a cyber...

HSBC Holdings plc (the ?Company', ?we' or ?us') announces the potential launch of an offering (the ?Offering') of a series of US dollar-denominated perpetual subordinated contingent convertible securities (the ?Securities'), subject to market...

Sea Limited ("Sea" or the "Company") today announced that it proposes to offer 11,000,000 American Depositary Shares ("ADSs"), each representing one Class A ordinary share of the Company, in an underwritten public offering. All of the ADSs to be...

U.S. Bancorp today announced that it will redeem on January 15, 2021 all of its outstanding Series H Non-Cumulative Perpetual Preferred Stock, par value $1.00 per share (the "Series H Preferred Stock"), and the corresponding depositary shares, each...

Frazier Healthcare Partners' special purpose acquisition corporation, Frazier Lifesciences Acquisition Corporation, announced the pricing of its initial public offering of 12,000,000 units, at a price to the public of $10.00 per unit, for aggregate...

Sequans Communications S.A. , ("Sequans" or the "Company"), a leading developer and provider of 5G and 4G chips and modules for IoT devices, today announced the pricing of an underwritten public secondary offering of 2,529,961 American Depositary...

Arcturus Therapeutics Holdings Inc. (the "Company", NASDAQ: ARCT), a leading clinical-stage messenger RNA medicines company focused on the development of infectious disease vaccines and significant opportunities within liver and respiratory rare...

Sequans Communications S.A. , ("Sequans" or the "Company"), a leading developer and provider of 5G and 4G chips and modules for IoT devices, today announced the launch of an underwritten public secondary offering of its American Depositary Shares...

Atara Biotherapeutics, Inc. , a pioneer in T-cell immunotherapy leveraging its novel allogeneic EBV T-cell platform to develop transformative therapies for patients with serious diseases including solid tumors, hematologic cancers and autoimmune...

Social Capital Hedosophia Holdings Corp. II ("SCH" and, after the Domestication as described below, "Opendoor Technologies") today announced the pending transfer of the listing of its Class A ordinary shares, par value $0.0001 per share (the "SCH...

Oblong, Inc. ("Oblong" or the "Company"), the award-winning maker of multi-stream collaboration solutions, today announced that it has entered into a definitive agreement with certain institutional and accredited investors to raise aggregate gross...

Saba Capital Management, L.P. and certain associated parties (collectively "Saba") today announced that it has reached an agreement with Royce Global Value Trust, Inc. (the "Fund"). Under the terms of the agreement, the Fund shall amend the terms...

Community Health Systems, Inc. (the "Company") announced today that it has entered into a privately negotiated agreement with a multi-asset investment manager who has certain funds and accounts, which are holders (the "Holders") of 6.875% Senior...

Turmeric Acquisition Corp. (the "Company") announced today that, commencing December 7, 2020, holders of the units sold in the Company's initial public offering of 9,775,000 units, completed on October 20, 2020, may elect to separately trade the...

IVERIC bio, Inc. today reported that on December 3, 2020, the Company granted a newly hired employee equity-based awards pursuant to the Company's 2019 Inducement Stock Incentive Plan. The inducement grants were approved by the Company's...

Regulatory News: The Rémy Cointreau Group (Paris:RCO) announces that it has sold its shares in the Passoã SAS joint venture to Lucas Bols Amsterdam B.V. for ? 71.3 million. The joint venture was formed in December 2016 to operate and further develop...

Voya Prime Rate Trust (the "Fund"), today announced the commencement of a tender offer for its outstanding common shares. As previously announced, the Fund will purchase for cash up to 15% of its outstanding common shares, at a price equal to 99%...

Central Securities Corporation announced today that the price at which Common Stock will be issued in payment of the $1.50 per share distribution payable on December 22, 2020 is $30.95 per share. This price is the arithmetic average of the daily...

Docebo Inc. ("Docebo" or the "Company") today announced the pricing of its previously announced marketed public offering of 3,000,000 common shares at a price to the public of US$48.00 per share in the United States and Canada, for aggregate gross...

Twist Bioscience Corporation , a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced the pricing of an underwritten public offering of 2,802,272 shares of its common...

AT&T Inc. ("AT&T") announced today pricing terms with respect to its private offers to (i) exchange four series of notes issued by AT&T (collectively, the "Pool 1 Notes") for a combination of cash and a new series of AT&T's senior notes to be due in...

NanoVibronix, Inc., , a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced that it has entered into securities purchase agreements...

Dicerna Pharmaceuticals, Inc. (the "Company" or "Dicerna"), a leading developer of investigational ribonucleic acid interference (RNAi) therapeutics, today announced that the Compensation Committee of the Company's Board of Directors approved...

Evoqua Water Technologies Corp. today announced the launch of a secondary public offering of 12 million shares of its common stock by certain institutional shareholders of the company, including certain affiliates of AEA Investors LP (collectively,...

Twist Bioscience Corporation , a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that it intends to offer and sell in an underwritten public offering up to $250...

Lonestar Resources US Inc. (the "Company" or "Lonestar") today announced that effective November 30, 2020, the Company has successfully completed its financial restructuring and emerged from Chapter 11 bankruptcy, having satisfied all of the...

Outset Medical, Inc. ("Outset"), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, announced today the commencement of a proposed underwritten public offering of 4,000,000 shares of...

MVB Financial Corp. ("MVB" or the "Company") announced today the completion of a private placement of $40 million of 4.25% fixed to floating rate subordinated notes due 2030 (the "Notes") to certain qualified institutional buyers. The Company...

Bill.com Holdings, Inc. ("Bill.com") today announced that it has closed its offering of 0% convertible senior notes due 2025 (the "notes") for gross proceeds of $1.15 billion. The proceeds include the full exercise of the $150.0 million option...

WestPark Capital, Inc., a full-service investment bank and securities broker-dealer, today announced the closing of the follow-on offering for its client Lixte Biotechnology Holdings, Inc. 1,200,000 units consisting of one share of common stock and...

Xeris Pharmaceuticals, Inc. , a specialty pharmaceutical company leveraging its novel technology platforms to develop and commercialize ready-to-use injectable and infusible drug formulations, today announced that on November 25, 2020, the...

TPG Pace Tech Opportunities Corp. (the "Company") announced that, commencing November 27, 2020, holders of the units sold in the Company's initial public offering of 45,000,000 units completed on October 9, 2020 may elect to separately trade the...

Acerus Pharmaceuticals Corporation ("Acerus" or the "Company") is pleased to announce the completion of its rights offering (the "Rights Offering"), which expired at 5:00 pm (EST) on November 24, 2020. The Rights Offering was over-subscribed and...